Product Code: 762
The biopreservation market is slated to depict significant growth through 2030 owing to favorable initiatives for the development of biopreservation applications. In addition, escalating incidences of chronic illnesses, along with heavy investment in the healthcare sector, is likely to further bolster market growth over the forecast period.
The COVID-19 pandemic curbed the supply chain operations, which in turn hampered overall market growth. However, increasing need for vaccines and medicines for COVID-19 and soaring prevalence of chronic diseases have accelerated product penetration. According to World Health Organization (WHO) data from June 2021, over 17.9 million people worldwide die each year due to cardiovascular illnesses, making it the leading cause of mortality.
Moreover, major industry players have been taking robust efforts to improve the efficiency of products while also engaging in various growth strategies, such as mergers, acquisitions, geographical expansion, collaborations, and so on, to maintain their market standing. For instance, in September 2022, Helmer Scientific, a medical storage company, announced the launch of GX Solutions Pharmacy and blood bank pass-thru refrigerators. This first-of-its-kind range of professional medical refrigerators and freezers has been optimized for critical healthcare applications.
The biopreservation market has been categorized in terms of product, cell provider, application, and region.
Based on product, the biopreservation industry has been segregated into equipment, media, and laboratory information management system (LIMS). The equipment segment is set to garner substantial gains by 2030 as biopreservation equipment viz., freezers, consumables, refrigerators, and liquid nitrogen are used extensively in the biopreservation of DNA, stem cells, plasma, and tissues, which are emerging as prominent research subjects.
With respect to cell provider, the biopreservation market has been divided into CD34+, CD19+, MSC, iPSC, hESC, and tumor cells. The MSC segment exceeded $762.6 million in revenue in 2021 and is primed to witness appreciable growth in the upcoming years. Mesenchymal stem cells (MSCs) are highly capable of self-renewal while maintaining the multipotency of the matter. Additionally, these cells have enormous therapeutic potential for tissue repair, which is foreseen to aid segmental growth.
On the other hand, the iPSC segment held more than 12.7% market share in 2021 due to rising demand for regenerative medicine, wherein iPSCs have promising applications as they can propagate indefinitely. Furthermore, increased investment in research activities and in exploring potential applications is projected to drive segmental progress.
Meanwhile, hESCs can differentiate into various cell types, and hence, they are useful in tissue engineering or transplantation. In 2021, the hESC segment captured a market share of approximately 14.5% and is set to observe strong development through 2030.
Regionally, the Middle East & Africa biopreservation market accounted for over 2.5% of the total industry revenue in 2021. Amplifying awareness regarding various medical check-ups is stimulating the demand for biopreservation techniques, which is propelling product demand in the MEA region.
Table of Contents
Chapter 1 Methodology & Scope
- 1.1 Methodology
- 1.2 Base estimates and working
- 1.2.1 North America
- 1.2.2 Europe
- 1.2.3 Asia Pacific
- 1.2.4 Latin America
- 1.2.5 MEA
- 1.3 Forecast parameters
- 1.4 Data validation
- 1.5 Data sources
- 1.5.1 Secondary
- 1.5.1.1 Paid sources
- 1.5.1.2 Public sources
- 1.5.2 Primary
Chapter 2 Executive Summary
- 2.1 Biopreservation market industry 360 degree synopsis, 2017 - 2030
- 2.1.1 Business trends
- 2.1.2 Product trends
- 2.1.3 Application trends
- 2.1.4 Cell provider trends
- 2.1.5 Regional trends
Chapter 3 Biopreservation Industry Insights
- 3.1 Industry segmentation
- 3.2 Industry landscape, 2017 - 2030
- 3.3 Industry impact forces
- 3.3.1 Growth drivers
- 3.3.1.1 Increasing investment in R&D
- 3.3.1.2 Rising healthcare expenditure
- 3.3.1.3 Advancement in biopreservation applications
- 3.3.1.4 Growing demand for regenerative medicine owing to rising prevalence of lifestyle diseases
- 3.3.2 Industry pitfalls & challenges
- 3.3.2.1 Requirement of room temperature storage technology
- 3.3.2.2 Stringent regulations pertaining to biopreservation
- 3.4 Growth potential analysis
- 3.4.1 By product
- 3.4.2 By application
- 3.4.3 By cell provider
- 3.5 COVID- 19 impact analysis
- 3.6 Porter's analysis
- 3.6.1 Bargaining power of suppliers
- 3.6.2 Bargaining power of buyers
- 3.6.3 Threat of new entrants
- 3.6.4 Threat of substitutes
- 3.7 Recent advancements in biopreservation
- 3.8 Legal and ethical guidelines for biopreservation
- 3.9 Applications of biopreservation
- 3.9.1 Stem cell preservation
- 3.9.2 Regenerative medicine
- 3.10 Top 10 stem cell banking companies
- 3.10.1 Average annual fee of stem cell banking
- 3.11 Competitive landscape, 2021
- 3.12 PESTEL analysis
Chapter 4 Biopreservation Market, By Product
- 4.1 Key segment trends
- 4.2 Equipment
- 4.2.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.2.2 Freezers
- 4.2.2.1 Market size, by region, 2017-2030 (USD Million)
- 4.2.3 Refrigerators
- 4.2.3.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.2.4 Consumables
- 4.2.4.1 Market size, by region, 2017-2030 (USD Million)
- 4.2.4.2 Vials
- 4.2.4.2.1 Market size, by region, 2017- 2030 (USD Million)
- 4.2.4.3 Straws
- 4.2.4.3.1 Market size, by region, 2017- 2030 (USD Million)
- 4.2.4.4 Microtiters
- 4.2.4.4.1 Market size, by region, 2017- 2030 (USD Million)
- 4.2.4.5 Bags
- 4.2.4.5.1 Market size, by region, 2017- 2030 (USD Million)
- 4.2.5 Liquid nitrogen
- 4.2.5.1 Market size, by region, 2017- 2030 (USD Million)
- 4.3 Media
- 4.3.1 Market size, by region, 2017- 2030 (USD Million)
- 4.3.2 Preformulated
- 4.3.2.1 Market size, by region, 2017- 2030 (USD Million)
- 4.3.3 Home-brew
- 4.3.3.1 Market size, by region, 2017- 2030 (USD Million)
- 4.4 Laboratory information management systems (LIMS)
- 4.4.1.1 Market size, by region, 2017- 2030 (USD Million)
Chapter 5 Biopreservation Market, By Application
- 5.1 Key segment trends
- 5.2 Regenerative medicine
- 5.2.1 Market size, by region, 2017 - 2030 (USD Million)
- 5.2.2 Cell therapy
- 5.2.2.1 Market size, by region, 2017- 2030 (USD Million)
- 5.2.3 Gene therapy
- 5.2.3.1 Market size, by region, 2017- 2030 (USD Million)
- 5.2.4 Others
- 5.2.4.1 Market size, by region, 2017- 2030 (USD Million)
- 5.3 Biobanking
- 5.3.1 Market size, by region, 2017 - 2030 (USD Million)
- 5.3.2 Human eggs
- 5.3.2.1 Market size, by region, 2017- 2030 (USD Million)
- 5.3.3 Human sperm
- 5.3.3.1 Market size, by region, 2017- 2030 (USD Million)
- 5.3.4 Veterinary IVF
- 5.3.4.1 Market size, by region, 2017- 2030 (USD Million)
- 5.4 Drug discovery
- 5.4.1 Market size, by region, 2017- 2030 (USD Million)
Chapter 6 Biopreservation Market, By Cell Provider
- 6.1 Key segment trends
- 6.2 CD34+
- 6.2.1 Market size, by region, 2017- 2030 (USD Million)
- 6.3 CD19+
- 6.3.1 Market size, by region, 2017- 2030 (USD Million)
- 6.4 MSC
- 6.4.1 Market size, by region, 2017- 2030 (USD Million)
- 6.5 iPSC
- 6.5.1 Market size, by region, 2017- 2030 (USD Million)
- 6.6 hESC
- 6.6.1 Market size, by region, 2017- 2030 (USD Million)
- 6.7 Tumor cells
- 6.7.1 Market size, by region, 2017- 2030 (USD Million)
- 6.8 Others
- 6.8.1 Market size, by region, 2017- 2030 (USD Million)
Chapter 7 Biopreservation Market, By Region
- 7.1 Key regional trends
- 7.2 North America
- 7.2.1 Market size, by country, 2017 - 2030 (USD Million)
- 7.2.2 Market size, by product, 2017 - 2030 (USD Million)
- 7.2.2.1 Market size by equipment, 2017- 2030 (USD Million)
- 7.2.2.1.1 Market size by consumables, 2017- 2030 (USD Million)
- 7.2.2.2 Market size by media, 2017- 2030 (USD Million)
- 7.2.3 Market size, by application, 2017 - 2030 (USD Million)
- 7.2.3.1 Market size by regenerative medicine, 2017- 2030 (USD Million)
- 7.2.3.2 Market size by biobanking, 2017- 2030 (USD Million)
- 7.2.4 Market size, by cell provider, 2017 - 2030 (USD Million)
- 7.2.5 U.S.
- 7.2.5.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.2.5.1.1 Market size by equipment, 2017- 2030 (USD Million)
- 7.2.5.1.1.1 Market size by consumables, 2017- 2030 (USD Million)
- 7.2.5.1.2 Market size by media, 2017- 2030 (USD Million)
- 7.2.5.2 Market size, by application, 2017 - 2030 (USD Million)
- 7.2.5.2.1 Market size by regenerative medicine, 2017- 2030 (USD Million)
- 7.2.5.2.2 Market size by biobanking, 2017- 2030 (USD Million)
- 7.2.5.3 Market size, by cell provider, 2017 - 2030 (USD Million)
- 7.2.6 Canada
- 7.2.6.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.2.6.1.1 Market size by equipment, 2017- 2030 (USD Million)
- 7.2.6.1.1.1 Market size by consumables, 2017- 2030 (USD Million)
- 7.2.6.1.2 Market size by media, 2017- 2030 (USD Million)
- 7.2.6.2 Market size, by application, 2017 - 2030 (USD Million)
- 7.2.6.2.1 Market size by regenerative medicine, 2017- 2030 (USD Million)
- 7.2.6.2.2 Market size by biobanking, 2017- 2030 (USD Million)
- 7.2.6.3 Market size, by cell provider, 2017 - 2030 (USD Million)
- 7.3 Europe
- 7.3.1 Market size, by country, 2017 - 2030 (USD Million)
- 7.3.2 Market size, by product, 2017 - 2030 (USD Million)
- 7.3.2.1 Market size by equipment, 2017- 2030 (USD Million)
- 7.3.2.1.1 Market size by consumables, 2017- 2030 (USD Million)
- 7.3.2.2 Market size by media, 2017- 2030 (USD Million)
- 7.3.3 Market size, by application, 2017 - 2030 (USD Million)
- 7.3.3.1 Market size by regenerative medicine, 2017- 2030 (USD Million)
- 7.3.3.2 Market size by biobanking, 2017- 2030 (USD Million)
- 7.3.4 Market size, by cell provider, 2017 - 2030 (USD Million)
- 7.3.5 Germany
- 7.3.5.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.3.5.1.1 Market size by equipment, 2017- 2030 (USD Million)
- 7.3.5.1.1.1 Market size by consumables, 2017- 2030 (USD Million)
- 7.3.5.1.2 Market size by media, 2017- 2030 (USD Million)
- 7.3.5.2 Market size, by application, 2017 - 2030 (USD Million)
- 7.3.5.2.1 Market size by regenerative medicine, 2017- 2030 (USD Million)
- 7.3.5.2.2 Market size by biobanking, 2017- 2030 (USD Million)
- 7.3.5.3 Market size, by cell provider, 2017 - 2030 (USD Million)
- 7.3.6 UK
- 7.3.6.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.3.6.1.1 Market size by equipment, 2017- 2030 (USD Million)
- 7.3.6.1.1.1 Market size by consumables, 2017- 2030 (USD Million)
- 7.3.6.1.2 Market size by media, 2017- 2030 (USD Million)
- 7.3.6.2 Market size, by application, 2017 - 2030 (USD Million)
- 7.3.6.2.1 Market size by regenerative medicine, 2017- 2030 (USD Million)
- 7.3.6.2.2 Market size by biobanking, 2017- 2030 (USD Million)
- 7.3.6.3 Market size, by cell provider, 2017 - 2030 (USD Million)
- 7.3.7 Italy
- 7.3.7.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.3.7.1.1 Market size by equipment, 2017- 2030 (USD Million)
- 7.3.7.1.1.1 Market size by consumables, 2017- 2030 (USD Million)
- 7.3.7.1.2 Market size by media, 2017- 2030 (USD Million)
- 7.3.7.2 Market size, by application, 2017 - 2030 (USD Million)
- 7.3.7.2.1 Market size by regenerative medicine, 2017- 2030 (USD Million)
- 7.3.7.2.2 Market size by biobanking, 2017- 2030 (USD Million)
- 7.3.7.3 Market size, by cell provider, 2017 - 2030 (USD Million)
- 7.3.8 UK
- 7.3.8.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.3.8.1.1 Market size by equipment, 2017- 2030 (USD Million)
- 7.3.8.1.1.1 Market size by consumables, 2017- 2030 (USD Million)
- 7.3.8.1.2 Market size by media, 2017- 2030 (USD Million)
- 7.3.8.2 Market size, by application, 2017 - 2030 (USD Million)
- 7.3.8.2.1 Market size by regenerative medicine, 2017- 2030 (USD Million)
- 7.3.8.2.2 Market size by biobanking, 2017- 2030 (USD Million)
- 7.3.8.3 Market size, by cell provider, 2017 - 2030 (USD Million)
- 7.3.9 France
- 7.3.9.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.3.9.1.1 Market size by equipment, 2017- 2030 (USD Million)
- 7.3.9.1.1.1 Market size by consumables, 2017- 2030 (USD Million)
- 7.3.9.1.2 Market size by media, 2017- 2030 (USD Million)
- 7.3.9.2 Market size, by application, 2017 - 2030 (USD Million)
- 7.3.9.2.1 Market size by regenerative medicine, 2017- 2030 (USD Million)
- 7.3.9.2.2 Market size by biobanking, 2017- 2030 (USD Million)
- 7.3.9.3 Market size, by cell provider, 2017 - 2030 (USD Million)
- 7.3.10 Spain
- 7.3.10.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.3.10.1.1 Market size by equipment, 2017- 2030 (USD Million)
- 7.3.10.1.1.1 Market size by consumables, 2017- 2030 (USD Million)
- 7.3.10.1.2 Market size by media, 2017- 2030 (USD Million)
- 7.3.10.2 Market size, by application, 2017 - 2030 (USD Million)
- 7.3.10.2.1 Market size by regenerative medicine, 2017- 2030 (USD Million)
- 7.3.10.2.2 Market size by biobanking, 2017- 2030 (USD Million)
- 7.3.10.3 Market size, by cell provider, 2017 - 2030 (USD Million)
- 7.4 Asia Pacific
- 7.4.1 Market size, by country, 2017 - 2030 (USD Million)
- 7.4.2 Market size, by product, 2017 - 2030 (USD Million)
- 7.4.2.1 Market size by equipment, 2017- 2030 (USD Million)
- 7.4.2.1.1 Market size by consumables, 2017- 2030 (USD Million)
- 7.4.2.2 Market size by media, 2017- 2030 (USD Million)
- 7.4.3 Market size, by application, 2017 - 2030 (USD Million)
- 7.4.3.1 Market size by Regenerative medicine, 2017- 2030 (USD Million)
- 7.4.3.2 Market size by biobanking, 2017- 2030 (USD Million)
- 7.4.4 Market size, by cell provider, 2017 - 2030 (USD Million)
- 7.4.5 China
- 7.4.5.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.4.5.1.1 Market size by equipment, 2017- 2030 (USD Million)
- 7.4.5.1.1.1 Market size by consumables, 2017- 2030 (USD Million)
- 7.4.5.1.2 Market size by media, 2017- 2030 (USD Million)
- 7.4.5.2 Market size, by application, 2017 - 2030 (USD Million)
- 7.4.5.2.1 Market size by regenerative medicine, 2017- 2030 (USD Million)
- 7.4.5.2.2 Market size by biobanking, 2017- 2030 (USD Million)
- 7.4.5.3 Market size, by cell provider, 2017 - 2030 (USD Million)
- 7.4.6 Japan
- 7.4.6.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.4.6.1.1 Market size by equipment, 2017- 2030 (USD Million)
- 7.4.6.1.1.1 Market size by consumables, 2017- 2030 (USD Million)
- 7.4.6.1.2 Market size by media, 2017- 2030 (USD Million)
- 7.4.6.2 Market size, by application, 2017 - 2030 (USD Million)
- 7.4.6.2.1 Market size by regenerative medicine, 2017- 2030 (USD Million)
- 7.4.6.2.2 Market size by biobanking, 2017- 2030 (USD Million)
- 7.4.6.3 Market size, by cell provider, 2017 - 2030 (USD Million)
- 7.4.7 India
- 7.4.7.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.4.7.1.1 Market size by equipment, 2017- 2030 (USD Million)
- 7.4.7.1.1.1 Market size by consumables, 2017- 2030 (USD Million)
- 7.4.7.1.2 Market size by media, 2017- 2030 (USD Million)
- 7.4.7.2 Market size, by application, 2017 - 2030 (USD Million)
- 7.4.7.2.1 Market size by regenerative medicine, 2017- 2030 (USD Million)
- 7.4.7.2.2 Market size by biobanking, 2017- 2030 (USD Million)
- 7.4.7.3 Market size, by cell provider, 2017 - 2030 (USD Million)
- 7.4.8 Australia
- 7.4.8.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.4.8.1.1 Market size by equipment, 2017- 2030 (USD Million)
- 7.4.8.1.1.1 Market size by consumables, 2017- 2030 (USD Million)
- 7.4.8.1.2 Market size by media, 2017- 2030 (USD Million)
- 7.4.8.2 Market size, by application, 2017 - 2030 (USD Million)
- 7.4.8.2.1 Market size by regenerative medicine, 2017- 2030 (USD Million)
- 7.4.8.2.2 Market size by biobanking, 2017- 2030 (USD Million)
- 7.4.8.3 Market size, by cell provider, 2017 - 2030 (USD Million)
- 7.4.9 South Korea
- 7.4.9.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.4.9.1.1 Market size by equipment, 2017- 2030 (USD Million)
- 7.4.9.1.1.1 Market size by consumables, 2017- 2030 (USD Million)
- 7.4.9.1.2 Market size by media, 2017- 2030 (USD Million)
- 7.4.9.2 Market size, by application, 2017 - 2030 (USD Million)
- 7.4.9.2.1 Market size by regenerative medicine, 2017- 2030 (USD Million)
- 7.4.9.2.2 Market size by biobanking, 2017- 2030 (USD Million)
- 7.4.9.3 Market size, by cell provider, 2017 - 2030 (USD Million)
- 7.5 Latin America
- 7.5.1 Market size, by country, 2017 - 2030 (USD Million)
- 7.5.2 Market size, by product, 2017 - 2030 (USD Million)
- 7.5.2.1 Market size by equipment, 2017- 2030 (USD Million)
- 7.5.2.1.1 Market size by consumables, 2017- 2030 (USD Million)
- 7.5.2.2 Market size by media, 2017- 2030 (USD Million)
- 7.5.3 Market size, by application, 2017 - 2030 (USD Million)
- 7.5.3.1 Market size by Regenerative medicine, 2017- 2030 (USD Million)
- 7.5.3.2 Market size by biobanking, 2017- 2030 (USD Million)
- 7.5.4 Market size, by cell provider, 2017 - 2030 (USD Million)
- 7.5.5 Brazil
- 7.5.5.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.5.5.1.1 Market size by equipment, 2017- 2030 (USD Million)
- 7.5.5.1.1.1 Market size by consumables, 2017- 2030 (USD Million)
- 7.5.5.1.2 Market size by media, 2017- 2030 (USD Million)
- 7.5.5.2 Market size, by application, 2017 - 2030 (USD Million)
- 7.5.5.2.1 Market size by regenerative medicine, 2017- 2030 (USD Million)
- 7.5.5.2.2 Market size by biobanking, 2017- 2030 (USD Million)
- 7.5.5.3 Market size, by cell provider, 2017 - 2030 (USD Million)
- 7.5.6 Mexico
- 7.5.6.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.5.6.1.1 Market size by equipment, 2017- 2030 (USD Million)
- 7.5.6.1.1.1 Market size by consumables, 2017- 2030 (USD Million)
- 7.5.6.1.2 Market size by media, 2017- 2030 (USD Million)
- 7.5.6.2 Market size, by application, 2017 - 2030 (USD Million)
- 7.5.6.2.1 Market size by regenerative medicine, 2017- 2030 (USD Million)
- 7.5.6.2.2 Market size by biobanking, 2017- 2030 (USD Million)
- 7.5.6.3 Market size, by cell provider, 2017 - 2030 (USD Million)
- 7.6 Middle East & Africa
- 7.6.1 Market size, by country, 2017 - 2030 (USD Million)
- 7.6.2 Market size, by product, 2017 - 2030 (USD Million)
- 7.6.2.1 Market size by equipment, 2017- 2030 (USD Million)
- 7.6.2.1.1 Market size by consumables, 2017- 2030 (USD Million)
- 7.6.2.2 Market size by media, 2017- 2030 (USD Million)
- 7.6.3 Market size, by application, 2017 - 2030 (USD Million)
- 7.6.3.1 Market size by regenerative medicine, 2017- 2030 (USD Million)
- 7.6.3.2 Market size by biobanking, 2017- 2030 (USD Million)
- 7.6.4 Market size, by cell provider, 2017 - 2030 (USD Million)
- 7.6.5 South Africa
- 7.6.5.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.6.5.1.1 Market size by equipment, 2017- 2030 (USD Million)
- 7.6.5.1.1.1 Market size by consumables, 2017- 2030 (USD Million)
- 7.6.5.1.2 Market size by media, 2017- 2030 (USD Million)
- 7.6.5.2 Market size, by application, 2017 - 2030 (USD Million)
- 7.6.5.2.1 Market size by regenerative medicine, 2017- 2030 (USD Million)
- 7.6.5.2.2 Market size by biobanking, 2017- 2030 (USD Million)
- 7.6.5.3 Market size, by cell provider, 2017 - 2030 (USD Million)
- 7.6.6 South Arabia
- 7.6.6.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.6.6.1.1 Market size by equipment, 2017- 2030 (USD Million)
- 7.6.6.1.1.1 Market size by consumables, 2017- 2030 (USD Million)
- 7.6.6.1.2 Market size by media, 2017- 2030 (USD Million)
- 7.6.6.2 Market size, by application, 2017 - 2030 (USD Million)
- 7.6.6.2.1 Market size by regenerative medicine, 2017- 2030 (USD Million)
- 7.6.6.2.2 Market size by biobanking, 2017- 2030 (USD Million)
- 7.6.6.3 Market size, by cell provider, 2017 - 2030 (USD Million)
Chapter 8 Company Profiles
- 8.1 Competitive dashboard, 2021
- 8.2 Thermo Fisher Scientific, Inc.
- 8.2.1 Business overview
- 8.2.2 Financial data
- 8.2.3 Product landscape
- 8.2.4 Strategic outlook
- 8.2.5 SWOT analysis
- 8.3 Arctiko A/S
- 8.3.1 Business overview
- 8.3.2 Financial data
- 8.3.3 Product landscape
- 8.3.4 Strategic outlook
- 8.3.5 SWOT analysis
- 8.4 Cryport, Inc
- 8.4.1 Business overview
- 8.4.2 Financial data
- 8.4.3 Product landscape
- 8.4.4 Strategic outlook
- 8.4.5 SWOT analysis
- 8.5 PHC Holdings Corporation
- 8.5.1 Business overview
- 8.5.2 Financial data
- 8.5.3 Product landscape
- 8.5.4 Strategic outlook
- 8.5.5 SWOT analysis
- 8.6 Eppendorf AG
- 8.6.1 Business overview
- 8.6.2 Financial data
- 8.6.3 Product landscape
- 8.6.4 Strategic outlook
- 8.6.5 SWOT analysis
- 8.7 VWR International (Avantor, Inc.)
- 8.7.1 Business overview
- 8.7.2 Financial data
- 8.7.3 Product landscape
- 8.7.4 Strategic outlook
- 8.7.5 SWOT analysis
- 8.8 Helmer Scientific
- 8.8.1 Business overview
- 8.8.2 Financial data
- 8.8.3 Product landscape
- 8.8.4 Strategic outlook
- 8.8.5 SWOT analysis
- 8.9 Biolife solutions
- 8.9.1 Business overview
- 8.9.2 Financial data
- 8.9.3 Product landscape
- 8.9.4 Strategic outlook
- 8.9.5 SWOT analysis
- 8.10 Merck KGaA
- 8.10.1 Business overview
- 8.10.2 Financial data
- 8.10.3 Product landscape
- 8.10.4 Strategic outlook
- 8.10.5 SWOT analysis
- 8.11 Azenta
- 8.11.1 Business overview
- 8.11.2 Financial data
- 8.11.3 Product landscape
- 8.11.4 Strategic outlook
- 8.11.5 SWOT analysis